Neudle.com: striatal lesion

Differential
(Click to cross reference)

abortion, spontaneous

abulia

acanthocytosis

aciduria

acquired immunodeficiency syndrome

ACTH

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

Aicardi-Goutieres syndrome

AMPA receptor antibodies

amyotrophic chorea-acanthocytosis

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, treatment of

aneurysm, intracranial

angiitis

angiography, cerebral

anosmia

anoxia

anterior choroidal artery

anti basal ganglia antibodies

anti GQ1b IgG antibody

anti Hu antibody

anti JC virus antibodies

anti-dopamine 2 receptor antibody

antihistamines

antineutrophil cytoplasmic autoantibodies

antisense therapy

antispasticity drugs

antistreptolysin titer

antiviral agents

anxiety

aortic valve, lesion of

arterial dissection, bilateral

arterial dissection, carotid

arterial dissection, spontaneous

atheromatous branch disease, intracranial

athetosis

atorvastatin

atrial myxoma

attention deficit disorder with hyperactivity

attention span

audiogram

auditory and vestibular pathways

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune GFAP astrocytopathy

automobile accidents

autonomic dysfunction

axonal degeneration

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

baclofen

bacterial infection

bacterial infection, CNS

ballismus, bilateral

Barkhof MR criteria for MS

basal cistern

basal ganglia

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, hemorrhage

basal ganglia, hemorrhage, bilateral

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

bee sting

bee sting, neurologic complications with

behavioral disorder

behavioral disorder, acute

biotin deficiency, juvenile form

biotin-responsive basal ganglia disease

blood dyscrasias, neurologic findings with

bone marrow suppression

bone marrow transplantation

border zone hypoperfusion

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brain transplantation

brain volume

brainstem, atrophy

brainstem, infarction of

calcification, intracranial

calcification, intracranial, rim

calmodulin kinase-like vesicle-associated protein

candida albicans

carbamazepine

carbon monoxide poisoning

cardiac arrest and resuscitation

carotid artery disease

carotid artery occlusion, intracranial

carotid artery occlusion, neck

carotid artery occlusion, neck-external and internal art patency with

carotid artery stenosis

carotid artery stenosis, bilateral

CAT scan

CAT scan, abnormal

CAT scan, angiography

CAT scan, chest

CAT scan, contrast enhanced

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, hyperattenuation

CAT scan, serial

catatonia

caudate nucleus

caudate nucleus, atrophy

caudate nucleus, hemorrhage of

caudate nucleus, infarction

caudate nucleus, lesion of

caudate nucleus, lesion of, bilateral

CD4 counts

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, primary

cerebellar lesion

cerebral arteries

cerebral arteries, territory of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral blood flow

cerebral cortex

cerebral cortical atrophy

cerebral embolism

cerebral embolism, cardiac origin

cerebral embolism, carotid origin

cerebral glucose metabolism

cerebral hypersensitivity, delayed

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebral palsy, associated problems with

cerebral vasculature

cerebral veins

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, complications with

cerebrovascular accident, delayed onset

cerebrovascular accident, etiology

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, location of

cerebrovascular accident, mimics

cerebrovascular accident, multiple

cerebrovascular accident, pathophysiology

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, silent

cerebrovascular accident, spontaneous improvement after

cerebrovascular accident, young adult

cerebrovascular disease

ceruloplasmin, serum

chemotherapy, CNS treatment and complications with

chest pain

chest x-ray, abnormal

choreoathetosis, paroxysmal

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

coma

complementary medicine

congenital infection, viral

congestive heart failure

conjunctival biopsy

contrast sensitivity

controversies in neurology

conus medullaris, lesion of

cooling therapy

cop 1

copper metabolism, abnormal

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

Creutzfeldt-Jakob disease, genetic

cryptococcal meningitis

cultured skin fibroblasts

cytomegalovirus infection

daclizumab

dantrolene sodium

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

delirium

dementia

dementia, cerebrovascular disease causing

dementia, rapidly progressive

dementia, subcortical

demyelinating disease

dentate nuclei, lesion of

depression

dermatomyositis

developmental retardation

dexamethasone suppression test

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diabetic ketoacidosis

diabetic striatopathy

diagnostic criteria

dialysis

diaminopyridine, 3, 4

diarrhea

diet

dietary supplement

differential diagnosis

digitalis

dilantin

diplegia, spastic cerebral

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

disulfiram

dizziness

dopa responsive dystonia

dopamine

dopamine receptor

dopamine receptor, D2

dorsal column stimulator

DPPX, antibodies, encephalitis

drug induced neurologic disorders

drug induced neurologic disorders in children

dyskinesia, buccal lingual facial

dystonia, delayed onset

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, symptomatic

dystonic reaction, acute

echocardiogram

efficacy

ejection fraction

ejection fraction, abnormal

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electron microscopy

embolism

embolism, carotid artery

emotional lability

empyema, epidural

encephalitis

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, parainfectious

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, acute necrotizing

encephalopathy, acute necrotizing of childhood

encephalopathy, anoxic

encephalopathy, parainfectious

encephalopathy, post anoxic

encephalopathy, progressive

endocarditis

enzyme, defect

eosinophilia

epidemiology of neurology

epidural steroid

Epstein-Barr virus

Epstein-Barr virus, negative

ethics in neurology

EVIDENCE trial

evidence-based research

evoked potentials

executive dysfunction

exercise

exercise-induced vascular symptoms

external capsule

eye movement, disorders of

facial weakness

faciobrachial dystonic seizure

fingolimod, discontinuation

frontal lobe, anatomy and physiology

frontal lobe, behavior with disease of

fumarate

fundus, abnormality of

fungal infection, CNS

gadolinium

gag reflex, depressed

gait disorder

gamma amino butyric acid receptor antibody

gamma amino butyric acid-mimetic drug

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, horizontal

genetic neurologic disorders

globus pallidus, hemorrhage

globus pallidus, infarction

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

glutamic acid decarboxylase, antibody

glutaric acidemia

glutaric aciduria

granular osmiphilic material

granulomatosis with polyangiitis

grasp reflex

gray matter

guanidine

Guillain Barre syndrome

gyrus, abnormal

Hallervorden Spatz disease

haloperidol

head injury

head injury, mild

head injury, pediatric

headache

headache, severe

hearing loss

heavy metal intoxication

hemophagocytic lymphohistiocytosis

hemorrhage, intracranial, newborn

hemorrhage, putamenal

hemorrhage, thalamic

hepatic failure

hepatitis

hepatolenticular degeneration(Wilson's disease)

hepatolenticular degeneration, non-Wilsonian

heralding manifestation

herniated disc, steroid treatment of

herpes simplex encephalitis

herpes simplex virus

herpes virus

herpes virus infection

herpes zoster

herpes zoster, disseminated

herpes zoster, ophthalmicus

Heubner's artery

high altitude sickness

highly active antiretroviral therapy

hippocampus

hippocampus, hyperintense

human immunodeficiency virus type 1

Huntington's chorea

Huntington's chorea, akinetic-rigid form

Huntington's chorea, presymptomatic detection of

Huntington's disease, children

hydrocephalus

hydrocephalus, exvacuo

hydrocephalus, transient

hyperglycemia, neurologic dysfunction associated with

hyperglycemia, nonketotic

hyperhidrosis

hypersensitivity reaction

hypoglycemia, newborn and infant

hypotension, systemic

hypothermia

hypoxia

hypoxia, intrauterine

hypoxia, newborn

hypoxic encephalopathy

iatrogenic neurologic disorders

ibuprofen

idiopathic thrombocytopenic purpura

imbalance

immune reconstitution inflammatory syndrome

immunohistochemistry

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inborn errors of metabolism

inclusion bodies

inclusion body myositis

incontinence, fecal

infantile bilateral striatal necrosis

infantile hemiplegia

infantile hemiplegia, causes of

infusion-associated reaction

intellectual deterioration

interferon

interferon alpha

interferon antibodies

interferon beta 1-a

interferon beta 1-b

interferon gamma

interferon, intrathecal

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, bilateral

intracerebral hemorrhage, causes of

intracerebral hemorrhage, differential diagnosis of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, multiple

intracerebral hemorrhage, young adult

intracranial pressure, increased

intrathecal antispasticity drugs

intrathecal steroid

intrauterine

intrauterine infection

intrauterine infection, viral

intrauterine infection, viral of CNS

intravenous

iron, brain

iron, serum, elevated

irritability

Isaacs syndrome

isoniazid

Jakob-Creutzfeldt disease

JC virus

Kayser-Fleischer ring

lactic acidemia

lactic dehydrogenase(LDH)

lacunar infarction

lacunar infarction, differential diagnosis of

lacunar state

laminar necrosis, cortical

laquinimod

laughing, pathologic

lead and the nervous system

lead poisoning

learning disability, in children

leg numbness

leg weakness, bilateral

Leigh's disease

Leigh's disease, adult variety

lenticular nucleus, infarction

lenticular nucleus, lesion of

lenticular nucleus, lesion of, bilateral

lenticulostriate arteries

Lesch-Nyhan syndrome

leucine rich glioma inactivated 1 antibodies

leukemia

leukemia, neurologic findings assoc.with

level of consciousness, decreased

limbic encephalitis

linomide

listeria monocytogenes

liver disease

liver function enzymes

lymphadenopathy

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphopenia

macular edema

magnetic susceptibility

malformation, vascular

malformation, vascular, cerebral

McDonald criteria for MS

meclizine

medication withdrawal

melanoma, malignant

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, basilar

meningitis, granulomatous

meningitis, late neurologic sequelae in

meningitis, neurologic aspects and complications of

meningitis, TB

meningoencephalitis

meningovascular syphilis

menses

menses, irregular

mental retardation

mental status, abnormal

mesial temporal lobe

metallic taste

methanol intoxication

methotrexate

microangiopathy, brain

microinfarcts

midbrain

midbrain, lesion of

middle cerebral artery territory infarction

middle cerebral artery, emboli to

middle cerebral artery, occlusion of

middle cerebral artery, stenosis of

migraine

mimics

Mini Mental Status Examination

misdiagnosis

mitochondrial disease

mitochondrial encephalomyopathy

mitoxantrone

modafinil

molecular genetics

monoclonal antibodies

mortality

motor neuron disease

movement disorder

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, field strength, high

MRI, FLAIR

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, hypointense signal foci on

MRI, indications for

MRI, lesion burden

MRI, magnetization transfer sequence

MRI, negative

MRI, optic nerve

MRI, paramagnetic effect

MRI, punctate pattern

MRI, susceptibility weighted

MRI, T1 weighted fat suppression

MRI, T1 weighted high signal foci

MRI, volumetry

MRS

mucormycosis

multinucleated giant cell

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, aggressive

multiple sclerosis, asymptomatic

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, diet in

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, early onset

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, lesion location

multiple sclerosis, linoleic acid in

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, preclinical

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

multiple sclerosis, worsening

multiple system atrophy

muscle atrophy, static

myasthenia gravis, drug induced

myasthenia gravis, treatment of

myasthenic syndrome

myasthenic syndrome, treatment of

mycophenolate

mycoplasma

mycoplasma pneumoniae

mycotoxin

myelin basic protein

myelinolysis, extrapontine

myelitis

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

N-acetyl-L-aspartic acid

natalizumab

natalizumab, discontinuation

nausea and vomiting

negative

neglect

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, peripheral nerve

neoplasm, primary of CNS

neoplastic angioendotheliosis

neurexin-3 alpha antibodies

neurofibromatosis 1

neurofilament light chain protein

neurogenic bladder

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic examination

neuromyelitis optica (Devic's disease)

neuromyotonia

neuronal cell surface antigen

neuronal ceroid-lipofuscinosis

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuroprotective agents

neutralizing antibodies

neutropenia

nevus

next-generation sequencing

nonsteroidal anti-inflammatory drug

Notch3 gene

nutritional deficiency

nystagmus

obsessive-compulsive disorder

occipital lobe, infarction

occipital lobe, lesion of

occupational neurologic disorders

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

optic atrophy

optic chiasm

optic nerve, lesion of

optic neuritis

optic neuritis, treatment of

optic neuropathy

optic neuropathy, toxic

optical coherence tomography

oral contraceptives

oral contraceptives, cerbrovascular disease and

organ transplantation

osmotic demyelination syndrome

outcome research

oxybutynin

pachymeningitis, cranial

Parkinson disease, acute onset

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

paroxysmal neurologic deficits

PAS positive

PAS positive material in the brain

patient information and support

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pemoline

pentoxifylline

periaqueductal lesion

pericarditis

perineural invasion

periodic alternating gaze

persistent vegetative state

personality change

photophobia

photosensitivity, skin

pituitary

placebo

plasmapheresis

pleocytosis of cerebrospinal fluid

pleurisy

poison, neurologic problems with

poliomyelitis-like illness

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

postural abnormality

potassium channel antibodies

potassium chlorate

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primrose oil

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

psychiatric problems in neurologic disorders

psychological testing

psychosis

ptosis

ptosis, unilateral

pulmonary infiltrates

pure motor hemiplegia

putamen, lesion of

putamen, lesion of, bilateral

pyramidal tract

pyramidal tract dysfunction

quality of life

radiation therapy, CNS treatment and complications with

radiation therapy, total body

radiculopathy

Ramsay Hunt syndrome

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

respiratory tract infection

retina, abnormal

retinitis pigmentosa

retinopathy

reversible neurologic disorder

risk-benefit assessment

sedimentation rate, elevated

serologic testing, false negative

seronegative

seropositive

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

shared decision making

sickle cell disease

simvastatin

sinemet

single photon emission computed tomography

skin, biopsy

skin, lesions in neurologic disorders

sleep pathology and physiology

spasticity, treatment of

spinal cord, enlargement

spinal cord, injury of

spinal cord, injury, management of

spinocerebellar ataxia type 1

spirochete infection

splenectomy

spongy degeneration of brain

statin therapy

status marmaratus

stem cell transplantation

stereotaxic surgery

steroid

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

stiff legs

stiff man syndrome

stimulation, deep brain

strangulation

streptococcal infection

striatal encephalitis

striatocapsular infarction

striatonigral degeneration

striatum, lesion of

striatum, lesion of, bilateral

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

sweating, abnormality of

swiss cheese brain

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

T cell lymphocytes

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamoperforating arteries

thalamotomy

thalamotuberal artery

thalamus

thalamus, infarction of

thalamus, lesion of

thalamus, lesion of-bilateral

thiamine

thiamine deficiency

third ventricle, wall

torticollis, post traumatic

toxic encephalopathy

toxins, nervous system

transient ischemic attack

trauma

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

tuberculin skin test, positive

tuberculosis

tuberous sclerosis

tumor necrosis factor

tumor necrosis factor inhibitor

unconsciousness

uremia

uremic encephalopathy

urinary incontinence

urinary retention

urinary tract infection

urodynamics

vaccination, neurologic complications with

vaccine

valium

valvulopathy

varicella zoster virus

varicella zoster virus, encephalitis

vasculitides

vasculopathy

vasopressin

ventricular enlargement

ventriculostomy

vertigo

vertigo, cervical

vertigo, treatment of

viral infection

viral infection, CNS

viral infection, reactivation

Virchow-Robin spaces, dilated

vision, blurred

vision, failure of in childhood

visual acuity

visual acuity, decreased

visual evoked response

visual loss

visual loss, progressive

visual loss, slow

vitamin D

vitamin deficiency

vitamin supplementation

vitamin, multiple

walking frame

walking, difficulty with

Wallerian degeneration

Wernicke's encephalopathy

West Nile fever

wheelchair

white matter disease

white matter disease, periventricular

white matter disease, subcortical

Showing articles 50 to 100 of 11489 << Previous Next >>

Acute Hippocampal and Chronic Diffuse White Matter Involvement in Severe Methanol Intoxication
Neurol 87:2382-2383, Takeshige, H.,et al, 2016

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

MRI Findings of Biotin-Responsive Basal Ganglia Disease Before and After Treatment
Neurol 86:e71-e72, Saeedan, M.B. & Dogar, M.A., 2016

Neuroradiologic Patterns and Novel Imaging Findings in Aicardi-Goutieres Syndrome
Neurol 86:28-35, La Piana, R.,et al, 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Rebound Syndrome in Patients with Multiple Sclerosis after Cessation of Fingolimod Treatment
JAMA Neurol 73:790-794, Hatcher, S.E.,et al, 2016

Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015

Newer Agents in the Treatment of Multiple Sclerosis
Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015

Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015

Oral Versus Intravenous High-Dose Methylprednisolone for Treatment of Relapses in Patients with Multiple Sclerosis (COPOUSEP):A Randomised, Controlled, Double-Blind,Non-Inferiority Trial
Lancet 386:974-981, LePage,E.,et al, 2015

Swiss Cheese Striatum
Neurohosp doi:1941874415586193, Finelli, P.F., 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Imaging Findings after Methanol Intoxication (Cohort of 46 Patients)
Neuro Endocrinol Lett 36:101-108, Vaneckova, M.,et al, 2015

Mycophenolate Mofetil in Multiple Sclerosis: A Multicentre Retrospective Study on 344 Patients
JNNP 85:279-283,246, Michel, L.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:1083-1092, Yadav, V.,et al, 2014

Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial
Lancet 383:2213-2221, Chataway, J.,et al, 2014

Striatocapsular Infarction; A Single Institutional Experience
Acta Inform Med 20:106-112, Amin, O.S.M.,et al, 2014

Neuroimaging in Patients with Abnormal Blood Glucose Levels
AJNR 35:833-840, Bathla, G.,et al, 2014

Swiss Cheese Striatum
JAMA Neurol 71:735-741, Burnett, M.S.,et al, 2014

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

CD49d Antisense Drug ATL1102 Reduces Disease Activity in Patients with Relapsing-Remitting MS
Neurol 83:1780-1788, Limmroth, V.,et al, 2014

Mycoplasma Pneumoniae Infection: Neurologic Complications
www.MedLink.com, Oct, Greenlee, J.E., 2013

Extensive Striatal, Cortical, and White Matter Brain MRI Abnormalities in Wilson Disease
Neurol 81:1557, Trocello, J.M.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Ann Neurol 73:705-713, Khan, O.,et al, 2013

Clinical Reasoning: A 28-year-old IV Drug User with Bilateral Basal Ganglia and Brainstem Lesions
Neurol 80:e73-e76, Lin, T.,et al, 2013

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis
Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012

Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012

Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes
Arch Neurol 69:183-190, Kinkel,R.P.,et al, 2012

Fingolimod-Associated Macular Edema
Neurol 78:672-680, Jain,N. and Bhatti,M.T., 2012

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
NEJM 366:1000-1009, Comi,G.,et al, 2012

Call It as You See It Evolution of Bilateral Striatal Necrosis
Neurol 78:e123, Coon,E.A. & Patterson,M.C., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

"Undiagnosing" Multiple Sclerosis
Neurol 78:1986-1991,1904, Solomon, A.J.,et al, 2012

Fulminant Encephalopathy With Basal Ganglia Hyperintensities in HIV-Infected Drug Users
Neurol 76:787-794, Newsome,S.D.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis
Ann Neurol 69:75-82, Comi,G.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011

Fulminant Encephalopathy with Basal Ganglia Hyperintensities in HIV-infected Drug Users
Neurol 77:923, Finelli, P.F., 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Showing articles 50 to 100 of 11489 << Previous Next >>